CARMAT
CARMAT is a medtech company, offering biocompatible, auto-regulated total artificial hearts, including right and left ventricles designed to be as close as possible to the human heart. It is designed for patients suffering from chronic terminal heart failure reaching class IV on the New York Heart Association classification; or acute terminal heart failure following a massive myocardial infarction. CARMATโs aim is to offer a reliable new treatment and innovative therapeutic solution to heart failure patients, who are not eligible for a transplant and who have exhausted every drug-related possibility. It was launched in 2008 by [Philippe Pouletty](https://www.crunchbase.com/person/philippe-pouletty) and is based in Vรฉlizy-villacoublay.
CARMAT
Industry:
Artificial Intelligence Health Care Information Technology
Founded:
2008-01-01
Address:
Vรฉlizy-villacoublay, Ile-de-France, France
Country:
France
Website Url:
http://www.carmatsa.com
Total Employee:
101+
Status:
Active
Contact:
+33139456450
Email Addresses:
[email protected]
Total Funding:
214 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Content Delivery Network Domain Not Resolving Nginx Sitelinks Search Box Euro
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - CARMAT
Truffle Capital
Truffle Capital investment in Funding Round - CARMAT
Official Site Inspections
http://www.carmatsa.com Semrush global rank: 4.41 M Semrush visits lastest month: 2.52 K
- Host name: undef-77-178.c-si.fr
- IP address: 91.151.77.178
- Location: Asnieres-sur-Seine France
- Latitude: 48.9119
- Longitude: 2.2875
- Timezone: Europe/Paris
- Postal: 92600